Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Danaher Stock Surged Today


's (NYSE: DHR) core revenue decline of 3.5% in the second quarter might not seem like anything to write home about. Still, as ever in investing, it's about context, and the company's earnings report shows that it's set to return to its long-term growth track.

The good news encouraged investors to bid the stock up by more than 7% in trading before 10 a.m. ET today.

As you might expect from a biotechnology, life sciences, and diagnostics company, Danaher's core revenue and earnings have bounced around in recent years due to the pandemic. Not only did Danaher manufacture PCR tests used to detect COVID-19, but it also sold life sciences equipment used to research vaccines.

Continue reading


Source Fool.com

Danaher Corp. Stock

€184.05
-0.490%
The price for the Danaher Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.900 (-0.490%).
With 45 Buy predictions and not a single Sell prediction Danaher Corp. is an absolute favorite of our community.
With a target price of 209 € there is a slightly positive potential of 13.56% for Danaher Corp. compared to the current price of 184.05 €.
Like: 0
DHR
Share

Comments